Show Less

The Reconfiguration of a Latecomer Innovation System

Governing Pharmaceutical Biotechnology Innovation in South Korea


Dirk Johann

The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance.


Show Summary Details
Restricted access

5 Evolving structures and dynamics of Korea’s innovation system for biotechnology


This chapter provides an analysis o f the institutional conditions and dynamics that shape the evolution o f the Korean sectoral pathway o f biotechnology development from a systems perspective. While the building o f a sectoral system is dependent on the configuration o f the national institutional framework to structure the effective management o f stocks and flows o f knowledge, the analysis centres upon the coordinative role o f the state in promoting sectoral innovation capabilities in biotechnology as well as on the evolving differentiation o f functions o f public and private actors engaged in the inherently uncertain environment o f biotechnology innovation and technology commercialisation. The chapter is divided in three parts. The first part starts with a brief historical review o f Korean biotechnology policies, focusing on the evolution of early frameworks to promote the emerging bioindustry and state-led initiatives to involve the private sector in collaborative biotechnology-related R&D activities. Actors and structures in policymaking and programme management are presented and the evolving division o f labour within the operating structure of the Korean national system o f biotechnology promotion is analysed. The second part discusses the framework conditions affecting the rate and direction of innovation in biotechnology. The recent reform o f the regulatory regime for intellectual property protection in public research organisations is outlined, the status o f bio-safety and bioethics-related laws and regulations is discussed, and the key issues o f the reform o f health policy regulations are presented. To...

You are not authenticated to view the full text of this chapter or article.

This site requires a subscription or purchase to access the full text of books or journals.

Do you have any questions? Contact us.

Or login to access all content.